Arrowhead Pharmaceuticals Ratios (2010-2025) | ARWR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Profitability
EBT Margin (Quarter)	-81.73%	-65.21%	-165.54%	-229.13%	29.23%	-222.28%	-260.20%	-66.82%	32.60%	-653.29%	-677.08%	-3,905.63%				-7,004.60%	68.11%	-644.97%	14.08%	10.71%
EBIT Margin (Quarter)	-86.04%	-69.44%	-169.48%	-230.77%	27.37%	-224.94%	-265.49%	-67.36%	32.93%	-648.99%	-672.98%	-3,845.25%				-6,456.48%	70.24%	-596.21%	17.20%	15.46%
EBITDA Margin (Quarter)	-82.03%	-65.29%	-165.88%	-229.28%	29.23%	-222.38%	-272.17%	-67.04%	32.54%	-658.48%	-707.13%	-3,756.94%				-7,033.24%	67.83%	-639.91%	6.71%	10.79%
Operating Margin (Quarter)	-86.04%	-69.44%	-169.48%	-230.77%	27.37%	-224.94%	-265.49%	-67.36%	32.93%	-648.99%	-672.98%	-3,845.25%				-6,456.48%	70.24%	-596.21%	17.20%	15.46%
Net Margin (Quarter)	-81.73%	-65.21%	-165.54%	-229.13%	29.23%	-222.28%	-272.18%	-66.82%	32.60%	-657.98%	-689.66%	-3,812.33%				-7,008.72%	67.78%	-643.40%	6.29%	10.70%
FCF Margin (Quarter)	782.38%	-73.09%	-84.18%	-244.49%	38.19%	-241.73%	-321.29%	-182.95%	-3.82%	-763.20%	-558.07%	-3,636.44%				-6,151.52%	86.09%	-610.58%	5.07%	5.05%
Efficiency
Assets Average (Quarter)	628.02M	745.86M	722.54M	674.34M	671.06M	727.68M	721.86M	791.71M	891.40M	843.58M	780.70M	695.92M	790.72M	919.45M	1,011.78M	1,076.75M	1,293.60M	1,477.06M	1,382.95M	1,494.74M
Equity Average (Quarter)	450.01M	441.22M	422.86M	390.69M	412.41M	463.22M	446.26M	407.36M	430.74M	423.55M	334.57M	230.44M	334.56M	417.19M	265.02M	123.57M	370.15M	603.27M	512.86M	535.92M
Invested Capital (Quarter)	445.55M	436.89M	408.82M	372.56M	452.27M	474.18M	418.34M	396.37M	465.11M	381.99M	287.16M	173.71M	495.40M	338.97M	191.06M	57.70M	749.23M	562.31M	543.42M	608.42M
Asset Utilization Ratio (Quarter)	0.14	0.14	0.19	0.21	0.39	0.34	0.34	0.35	0.31	0.30	0.31	0.26	0.04	0.02	0.00	0.00	0.42	0.39	0.60	0.73
Leverage & Solvency
Interest Coverage Ratio (Quarter)								-14.79	9.52	-19.91	-20.59	-25.44	-17.42	-34.58	-11.07	-7.46	17.62	-6.79	2.03	1.81
Debt to Equity (Quarter)															2.06	7.30	0.40	0.46	0.51	0.36
Debt Ratio (Quarter)															0.34	0.40	0.17	0.17	0.18	0.13
Equity Ratio (Quarter)	0.59	0.59	0.58	0.58	0.64	0.63	0.60	0.44	0.52	0.48	0.38	0.28	0.52	0.38	0.17	0.06	0.43	0.38	0.36	0.35
Times Interest Earned (Quarter)								-14.79	9.52	-19.91	-20.59	-25.44	-17.42	-34.58	-11.07	-7.46	17.62	-6.79	2.03	1.81
Valuation
Enterprise Value (Quarter)	-498.17M	-389.92M	-241.06M	-126.01M	-279.30M	-396.25M	-356.58M	-482.52M	-462.62M	-434.55M	-387.81M	-207.01M	-511.50M	-428.27M	-675.34M	-549.45M	-1096.51M	-902.89M	-882.00M	-922.34M
Return Ratios
Return on Sales (Quarter)	-0.82%	-0.65%	-1.66%	-2.29%	0.29%	-2.22%	-2.72%	-0.67%	0.33%	-6.58%	-6.90%	-38.12%	-13.46%	-27.86%	-171.70%	-70.09%	0.68%	-6.43%	0.06%	0.11%
Return on Capital Employed (Quarter)	-0.26%	-0.24%	-0.26%	-0.35%	-0.22%	-0.27%	-0.31%	-0.23%	-0.19%	-0.23%	-0.30%	-0.47%	-0.65%	-0.67%	-0.66%	-0.64%	-0.11%	-0.08%	0.08%	0.26%
Return on Invested Capital (Quarter)			-0.35%	-0.48%	-0.29%	-0.34%	-0.41%	-0.40%	-0.36%	-0.44%	-0.62%	-1.30%	-1.41%	-1.31%	-2.26%	-5.04%	-0.30%	-0.17%	0.10%	0.48%
Return on Assets (Quarter)	-0.17%	-0.17%	-0.19%	-0.27%	-0.17%	-0.21%	-0.24%	-0.20%	-0.17%	-0.22%	-0.27%	-0.44%	-0.60%	-0.60%	-0.60%	-0.60%	-0.12%	-0.11%	0.02%	0.16%
Return on Equity (Quarter)	-0.24%	-0.29%	-0.33%	-0.47%	-0.27%	-0.33%	-0.40%	-0.38%	-0.35%	-0.43%	-0.63%	-1.31%	-1.43%	-1.31%	-2.30%	-5.26%	-0.42%	-0.26%	0.06%	0.44%

Research Tools

Arrowhead Pharmaceuticals Ratios (2010-2025) | ARWR

Create an account

Sign In

Reset Password